XALKORI
Identification of Xalkori
| No description |
Google image searchProduct monograph
Active ingredient
crizotinib, 250 MG
DIN: 02384264
Dosage form(s): CAPSULE
Route(s) of administration: ORAL
Schedule: Prescription
Company: PFIZER CANADA ULC
Date: 10-MAY-2012
ATC:
- L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
- L01E — PROTEIN KINASE INHIBITORS (ATC, ATC/DDD)
- L01ED — Anaplastic lymphoma kinase (ALK) inhibitors (ATC, ATC/DDD)
- L01ED01 — CRIZOTINIB (ATC/DDD)
Reference brand drug: Xalkori
